The efficacy of the third pump inhibitor - pantoprazole - in the short-term treatment of Chinese patients with duodenal ulcer

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2372-2378

  Chen, Tseng Shing ^a   Chang, Full Young ^a,b   Ng, Wai Wah ^a   Lee, Fa Yauh ^a   Hwang, Shinn Jang ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Duodenal ulcer; Helicobacter pylori; Pantoprazole

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ABDOMINAL DISTENSION; ADULT; AGED; ARTHRALGIA; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DUODENOSCOPY; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; ULCER HEALING; UPPER RESPIRATORY TRACT INFECTION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; FEMALE; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPSINOGEN A; PROTON PUMPS; RANITIDINE; SULFOXIDES;

EID: 0032854995     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Simon WA, Keeling DJ, Laing SM, Fallowfield C, Taylor AG: BY1023/SK&F96022: biochemistry of a novel (H'+K')-ATPase inhibitor. Biochem Pharmacol 1990; 39:1799-1806.
2. Simon WA, Budingen C, Fahr S, Kinder B, Koske M: The H', K'-ATPase inhibitor (H'+K')-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochem Pharmacol 1991; 42:347-355.
3. Steinijans VM: Pantoprazole: pharmacokinetics and drag interactions in man. International Journal Of Clinical Pharmacology and Therapeutics 1996; 34(Suppl 1):S1-S85.
4. Cremer M, Lambert R, Lamers CBHW, Fave GD, Maier C, the European Pantoprazole Study Group: A double-blind study of pantoprazole and tanitidine in treatment of acute duodenal ulcer. A multicenter trial. Dig Dis Sci 1995; 40:1360-1364.
5. Lam SK, Hasan M, Sircus W, et al: Comparision of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980; 21:324-328.
6. Graham DY, Genta R, Evans DG, Reddy R, Clarridge JE, Olson CA, Edmonds AL, Siepman N: Helicobacter pylori dose not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1996; 91:2120-2124.
7. Ogoshi K, Kato T, Sakagawa T: Peptic ulcer therapy with lansoprazole with Helicobacter pylori eradication. J Clin Gastroenterol 1995; 20(Suppl 2): S97-S99.
8. Fitton A, Wiseman L: Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51:460-482.
9. Chen TS, Chang FY, Lee SD: A single standard nocturnal dose of nizatidine enhances the healing of active duodenal ulcers among Chinese. J Gastroenterol Hepatol 1995; 10:135-139.
10. Schepp W, Classen M: Pantoprazole and ranitidine in the teatment of acute duodenal ulcer. A multicentre study. Scand J Gastroenterol 1995; 30:511-514.
11. Reil L, Erhardt F, Fischer R, Londong W: Intragastric pH and serum gastrin after one week treatment with pantoprazole, ranitidine or placebo in man. Gastroenterol 1993; 104:A177.
12. Festen HPM, Thijs JC, Lamers CBHW, Jansen JMB, Pals G, Frants RR, Defize J, Meuwissen SGM: Effect of oral omeprazole and on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984; 87:1030-1034.
13. Lysy J, Karmeli F, Wengrower D, Rachmilewitz D: Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients. Stand J Gastroenterol 1992; 27:13-19.
14. Suerbaum S, Leying H, Klemm K, et al: Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10:92-93.
15. Arachimandritis C, Tjivras M, Davaris P, Fertakis A: Effect of omerazole of H. pylori after 2 weeks of treatment. Italian Journal Gastroenterology 1991; 23:357-358.
16. Hui WM, Lam SK, Ho J, Lai CL, Lok ASF, Ng MMT, et al: Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991; 36:577-582.
17. Chang FY, Chiang CY, Tam TN, Ng WW, Lee SD: Comparison or lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan. J Gastroenterol Hepatol 1995; 10:595-601.
18. Chen TS, Chang FY, Lee SD: A biopsy urease test in the detection of Helicobacter pylori: comparison of antral and body specimens. Chin Med J 1995; 55:361-365.
19. Chiverton SG, Burget DW, Hunt RH: Response surface methodology predicts duodenal ulcer healing from acid suppression data. Gut 1988; 29:A711.
20. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH: Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36:12-16.
21. Hentschel E, Brandstter G, Dragosics B, et al: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328:308-312.
22. Jhala NC, MCFarland MM, Brightman SA, Morale BM, Rubin W, Atkinson BF: The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. Am J Gastroenterol 1995; 90:1824-1828.